Published Date: 2021-01-16
Request a sample
According to the Graphical Research new growth forecast report titled “Asia Pacific Electrophysiology (EP) Market Size By Product (EP Ablation Catheters {Radiofrequency, Cryoablation, Laser}, EP Diagnostic Catheters {Conventional, Advanced, Ultrasound}, EP Laboratory Devices {Mapping Systems, Recording Systems}), By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Re-entry Tachycardia), By End-use (Hospitals, Catheterization Laboratories/EP Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam)”, Estimated To Exceed USD 2.5 Billion By 2027
Increasing prevalence of cardiac disorders such as atrial fibrillation, atrial flutter and tachycardia among others in the region and launch of new advanced products will influence electrophysiology revenue growth during forecast period.
The recent COVID-19 pandemic has negatively impacted the electrophysiology procedures upto some extent. Elective procedures were differed during the initial phase of the outbreak to reduce cross contamination in healthcare settings. However, as COVID-19 cases are declining across the globe, the APAC electrophysiology market will witness gradual growth in the future.
Growing geriatric pool coupled with rising prevalence of atrial fibrillation in Asia Pacific countries will drive the market growth in the future. Incidence of atrial fibrillation (AF) has considerably increased over the past decade in the region. Age, smoking, obesity and sedentary lifestyles are the major factors that potentially results into cardiac arrhythmias. Increasing patient pool coupled with rising treatment through electrophysiology will further drive the business growth over the forecast timeframe.
Technological advancements in cardiac mapping and ablation will significantly impact the APAC electrophysiology market growth in the upcoming years. Product innovations including integration of robotics in mapping systems to enable faster tracking of EP procedures will play a vital role in stimulating market growth. Furthermore, rising awareness and growing adoption of catheter ablation procedure in the region will augment the market growth during the forecast period. However, high cost of electrophysiology devices and limited skilled professionals in the emerging economies may hamper its market growth up to some extent.
EP diagnostic catheters segment constituted about more than 35% revenue share in 2020. Diagnostic EP catheters are used for diagnostic purpose EP procedures to confirm the detection of atrial fibrillation and determine the most appropriate treatment. Moreover, increasing prevalence of obesity and growing elderly population base, surging the risk of rhythm disorders will drive the demand for EP diagnostic procedures, thereby favoring the segmental growth.
Atrial tachycardia segment accounted for over USD 25 million in 2020. Increasing consumption of drugs/alcohol, leading to infections will trigger increase in incidence rate of atrial tachycardia. Development of catheters for ablation of atrial tachycardia coupled with escalating number of procedures will further offer robust segmental growth in foreseeable future.
Catheterization laboratories/EP laboratories segment is expected to progress at over 14% CAGR during the projection period. Ability to provide varied and technologically advanced products and presence of skilled professionals will boost segmental growth. Growing burden of atrial fibrillation and other cardiac arrythmias coupled with increasing geriatric population pool will have a significant impact on catheterization laboratories/EP laboratories segment growth in the foreseeable future.
India electrophysiology market is forecasted to grow at 13.0% CAGR during forecast timeframe. Improving healthcare infrastructure and entry of major market players are some of the growth driving factors. Growing adoption of advanced electrophysiology products along with high prevalence of atrial fibrillation in India will positively impact regional revenue share. Moreover, the Asia Pacific Heart Rhythm Society (APHRS) aims at creating infrastructure for clinical research regarding cardiac electrophysiology and arrhythmia in various countries across the region, thus fostering the market growth in the country.
Major key players in APAC electrophysiology market are GE Healthcare, Johnson & Johnson (Biosense Webster), Medtronic, Abbott Laboratories, Japan Lifeline, Koninklijke Philips N.V., and Boston Scientific Corporation among other market players. These market players are undertaking various market strategies such as product innovation, mergers and acquisition acquisitions to set their footprint in the region. For instance, in March 2019, GE Healthcare and Siemens Inc. joined together for launch of cardiac CT scanner. Collaboration will help the organization to develop and manufacture technologically advanced product for accurate heart imaging and diagnosis. This strategic partnership helped the organization in increasing product reach & revenue growth.
APAC electrophysiology market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:
APAC Electrophysiology Market, By Product, 2016-2027 (USD Million)
APAC Electrophysiology Market, By Indication, 2016-2027 (USD Million)
APAC Electrophysiology Market, By End-use, 2016 – 2027 (USD Million)
The above information is provided for the following region and countries:
LSI keywords:
The great explorer of the truth, the master-builder of human happiness no one rejects dislikes avoids pleasure itself because it is pleasure but because know who do not those how to pursue pleasures rationally encounter consequences that are extremely painful desires to obtain.
Read More